Products - Multiple sclerosis | Topic | NICE

Showing 6 products

Date | Title

Status: Topic selectionRemove ‘Status: Topic selection’ filter

Autologous unmanipulated peripheral blood stem cell therapy for multiple sclerosis
Status:
Topic selection
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Fingolimod for treating relapsing multiple sclerosis in children and young people [ID1378]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Glatiramer acetate depot for multiple sclerosis [TS ID 10620]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Natalizumab for treating highly active relapsing-remitting multiple sclerosis [ID4020]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Dimethyl fumarate for treating relapsing-remitting multiple sclerosis in people aged 13 to 17 TS ID 11778
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Subcutaneous ocrelizumab for treating primary progressive or relapsing multiple sclerosis TS ID 11895
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC